Spatial navigation in preclinical Alzheimer's disease: A review

Fuente: arXiv
Saved in:
Bibliographic Details
Main Authors: Salouhou, Syrine, Gilles, Victor, Vallée, Remi, Coughlan, Gillian T., Bachelet, Romain, Hornberger, Michael, Spiers, Hugo, Coutrot, Antoine, Garnier-Crussard, Antoine
Format: Preprint
Published: 2026
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866918406449528832
author Salouhou, Syrine
Gilles, Victor
Vallée, Remi
Coughlan, Gillian T.
Bachelet, Romain
Hornberger, Michael
Spiers, Hugo
Coutrot, Antoine
Garnier-Crussard, Antoine
author_facet Salouhou, Syrine
Gilles, Victor
Vallée, Remi
Coughlan, Gillian T.
Bachelet, Romain
Hornberger, Michael
Spiers, Hugo
Coutrot, Antoine
Garnier-Crussard, Antoine
contents Alzheimer's disease (AD) develops over a prolonged preclinical phase, during which neuropathological changes accumulate long before cognitive symptoms appear. Identifying cognitive functions affected at early stages is critical for the preclinical detection of asymptomatic individuals at-risk of AD. Early risk identification could enable timely interventions aimed at mitigating the development of significant future cognitive impairment. While episodic memory decline typically appears after substantial medial temporal lobe damage, spatial navigation has emerged as a particularly sensitive cognitive function in preclinical AD. In this review, we provide an overview of spatial navigation computations and the tasks used to assess them, highlighting how spatial navigation relies on neural circuits corresponding to the earliest sites of AD pathology. We synthesize evidence from cognitively unimpaired individuals with AD biomarkers, i.e. individuals at-risk of AD, and discuss future research directions. Overall, performance on spatial navigation tasks, particularly path integration and wayfinding, correlates with plasma and CSF biomarkers of AD pathology, notably p-tau. Spatial navigation assessment can represent a sensitive and scalable approach for early detection of individuals at-risk of AD in preclinical stages, and will inform future interventions to mitigate the progression toward clinically significant cognitive impairment.
format Preprint
id arxiv_https___arxiv_org_abs_2603_23082
institution arXiv
publishDate 2026
record_format arxiv
spellingShingle Spatial navigation in preclinical Alzheimer's disease: A review
Salouhou, Syrine
Gilles, Victor
Vallée, Remi
Coughlan, Gillian T.
Bachelet, Romain
Hornberger, Michael
Spiers, Hugo
Coutrot, Antoine
Garnier-Crussard, Antoine
Neurons and Cognition
Alzheimer's disease (AD) develops over a prolonged preclinical phase, during which neuropathological changes accumulate long before cognitive symptoms appear. Identifying cognitive functions affected at early stages is critical for the preclinical detection of asymptomatic individuals at-risk of AD. Early risk identification could enable timely interventions aimed at mitigating the development of significant future cognitive impairment. While episodic memory decline typically appears after substantial medial temporal lobe damage, spatial navigation has emerged as a particularly sensitive cognitive function in preclinical AD. In this review, we provide an overview of spatial navigation computations and the tasks used to assess them, highlighting how spatial navigation relies on neural circuits corresponding to the earliest sites of AD pathology. We synthesize evidence from cognitively unimpaired individuals with AD biomarkers, i.e. individuals at-risk of AD, and discuss future research directions. Overall, performance on spatial navigation tasks, particularly path integration and wayfinding, correlates with plasma and CSF biomarkers of AD pathology, notably p-tau. Spatial navigation assessment can represent a sensitive and scalable approach for early detection of individuals at-risk of AD in preclinical stages, and will inform future interventions to mitigate the progression toward clinically significant cognitive impairment.
title Spatial navigation in preclinical Alzheimer's disease: A review
topic Neurons and Cognition
url https://arxiv.org/abs/2603.23082